American Heart Association
Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)
ISC Invited Symposium
Hall H&J, AHA HeadQuarters, Neuro Talk Theater
Feb 6th , 03:40 PM - 04:00 PM
03 : 40 PM
Q&A Session: Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20)
Awad Issam
Final Pr. ID: -
Authors: Awad Issam
03 : 40 PM
Q&A Session: Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20)
Awad Issam
Final Pr. ID: -
Authors: Awad Issam